Company News Avance Clinical Featured in Endpoints News on Cell & Gene Therapy Capabilities The cell and gene therapies (CGT) sector offers unprecedented opportunities for patient disease management across…News EditorNovember 25, 2021
Company News Avance Clinical Featured in Fierce Biotech on Intranasal Expertise With the global intranasal drug delivery market estimated to reach up to $71 billion over…News EditorOctober 23, 2021
Client News Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the…News EditorOctober 18, 2021
Company AwardsCompany News Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious…News EditorAugust 10, 2021
Client NewsCompany News Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market…News EditorJuly 9, 2021